TransEnterix CEO steps down amid company’s financial struggles

//TransEnterix CEO steps down amid company’s financial struggles

TransEnterix CEO steps down amid company’s financial struggles

The CEO of a Triangle bio-tech firm is stepping down as the company continues to look for ways to finance its operations beyond the first quarter of next year. Research Triangle Park-based TransEnterix (NYSE: TRXC) has announced its long-time president and CEO – Todd Pope – is stepping down effective immediately. According to a company statement, Pope will remain on as a "senior advisor to the company." Pope served as CEO since 2008. His base salary in 2018 was $480,800, according to the…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-11-08T22:45:12+00:00 November 8th, 2019|Healthcare|

About the Author: